PARATEK PHARMACEUTICALS INC - COM (PRTK)

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / COM
Total 13F shares
23,255,389
Share change
+2,032,642
Total reported value
$59,046,370
Put/Call ratio
52%
Price per share
$2.54
Number of holders
61
Value change
+$5,498,868
Number of buys
25
Number of sells
37

Institutional Holders of PARATEK PHARMACEUTICALS INC - COM (PRTK) as of Q1 2023

As of 31 Mar 2023, PARATEK PHARMACEUTICALS INC - COM (PRTK) was held by 61 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,255,389 shares. The largest 10 holders included AIGH Capital Management LLC, NEXPOINT ASSET MANAGEMENT, L.P., VANGUARD GROUP INC, Omega Fund Management, LLC, GENERAL AMERICAN INVESTORS CO INC, Rock Springs Capital Management LP, Bruce & Co., Inc., BlackRock Inc., Carlyle Group Inc., and J. Goldman & Co LP. This page lists 61 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.